Schizophrenia Research

Article	Citations
Elevated triglycerides and low triiodothyronine: Key risk factors for coronary artery calcification in patients with schizophrenia	176
Exploring associations between trait symptoms and speech patterns in schizophrenia spectrum disorders: A mediation analysis	103
Reply to Dyadic interaction in schizophrenia – A promising new avenue of investigation?	99
Construction of extra-large scale screening tools for risks of severe mental illnesses using real world healthcare data	92
Trends in socioeconomic inequalities in incidence of severe mental illness – A population-based linkage study using primary and secondary care routinely collected data between 2000 and 2017	69
Meta-analysis of a family history of diabetes in schizophrenia	66
A profile of high scores on the Peters delusion inventory and low engagement in pandemic-related health behaviors in a non-clinical sample	51
Comorbid psychosis in temporal lobe epilepsy is associated with auditory emotion recognition impairments	49
Alterations in fatty acid metabolism in patients with schizophrenia in a multi-omics perspective	44
Frequency of clinical appointments in subjects with emergent suicidal ideation	44
Comments on the manuscript: Arthur Schopenhauer: An underappreciated philosopher in psychiatry and his applied epistemology of body and self-experience	44
Can clozapine be used for treatment-refractory behavioral and psychological symptoms in dementia patients?	42
Rethinking psychosis: Time to retire “organic”, “idiopathic” and “secondary”?	42
Increased likelihood of distressing and functionally impairing psychotic-like experiences among children with co-occurring internalising and externalising problems	40
Issue Highlights	40
The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: A population-based cohort study	38
Denial of anosognosia in schizophrenia	37
The potential of AI for scale development: A self-report psychosis symptoms measure using ChatGPT	37
Exploring peripheral biomarkers of response to simvastatin supplementation in schizophrenia	37
Hippocampus in the symptom architecture of schizophrenia spectrum disorders: A network analysis approach	36
Association between negative symptoms and health-related quality of life and functional outcomes in persons with schizophrenia: A systematic review	35
The impact of daily social support on the associations between daily negative events and daily suspiciousness across different clinical stages of psychosis	35
Measurement invariance of the Revised-Green Paranoid Thought Scale across Black and White Americans	34
Polygenic risk score of glycemic homeostasis, Type 2 Diabetes Mellitus and glycemic components in first episode psychosis	32
Effect of add-on tDCS therapy for auditory hallucinations on frequency and duration deviant mismatch negativity in schizophrenia	32

Substance use and self-poisoning in schizophrenia: 11-year findings from a national clinical survey of suicide in mental health patients in the UK	31
Human endogenous retroviruses type W (HERV-) activation and schizophrenia: A meta-analysis	31
Recovery from leukopenia after discontinuation of clozapine does not exclude lymphoma	31
A 20-year review comparing the use of ‘schizophrenia’ and ‘psychosis’ in UK newspapers from 2000 to 2019: Implications for stigma reduction	31
App for independence: A feasibility randomized controlled trial of a digital health tool for schizophrenia spectrum disorders	31
Automated linguistic analysis in speech samples of Turkish-speaking patients with schizophrenia-spectrum disorders	31
Factors associated with employment and hospitalizations in early-onset psychosis: a clinical study with register-based follow-up	30
Associations between acceptance of the implausible bias, theory of mind and delusions in first-episode psychosis patients; A longitudinal study	30
Exploring phenotypic overlap across schizotypy and autism spectrum conditions in American and Chinese young adults	29
Everyday function in schizophrenia: The impact of aerobic endurance and skeletal muscle strength	29
Overactive, aggressive, disruptive and agitated behavior associated with the use of psychotropic medications in schizophrenia	28
A high-resolution plasma proteomic framework for stratifying treatment resistance and ultra-resistance in schizophrenia	28
Issue highlights	28
Interpersonal distance in schizophrenia: A systematic review	27
Creating a collaborative culture of learning within a network of community mental health early psychosis programs in Texas	27
Ethno-racial variation in psychotic experiences in the United States: Findings from the National Latino and Asian American Survey and the National Survey of American Life	27
Exploring the conceptualisation, measurement, clinical utility and treatment of formal thought disorder in psychosis: A Delphi study	27
Allostatic load, sleep patterns, and genetic susceptibility in relation to severe mental illness: A prospective cohort study	27
The schizophrenia syndrome, circa 2024: What we know and how that informs its nature	26
Early cognitive development and psychopathology in children at familial high risk for schizophrenia	26
Effect of anticholinergic burden on brain activity during Working Memory and real-world functioning in patients with schizophrenia	26
Association between initial clozapine titration and pneumonia risk among patients with schizophrenia in a Korean tertiary hospital	25
Testing two theories of social support benefits and implications for individuals with psychotic-like experiences	25
Selection bias in clinical studies of first-episode psychosis: A follow-up study	25
The validity of atypical psychosis diagnostic criteria to detect anti-NMDA receptor encephalitis with psychiatric symptoms	24
Deciphering language disturbances in schizophrenia: A study using fine-tuned language models	24
Immunosenescence-related T cell phenotypes and white matter in schizophrenia patients with tardive dyskinesia	24
Changes in degree centrality and its associated genes: A longitudinal study of patients with schizophrenia undergoing pharmacological treatment	24
Climatic exposures in childhood and the risk of schizophrenia from childhood to early adulthood	24
Improved quality of life with semaglutide in schizophrenia: Secondary analyses from a randomized controlled trial	24
Arousal responses to personal space intrusions in psychotic illness: A virtual reality study	24
Insomnia and substance use in psychotic disorders	24
Mismatch negativity in schizophrenia spectrum and bipolar disorders: Group and sex differences and associations with symptom severity	24
Issue Highlights	24
Clozapine discontinuation and rechallenge in suspected myocarditis: An analysis of seven cases	23
Schizophrenia among young people first admitted to psychiatric inpatient care during early and middle adolescence	23
Spontaneous neural activity underlying neutral and happy speech recognition in noise and its association with psychiatric symptoms in patients with schizophrenia	23
Computational psychiatry and the psychopathology of psychosis: Promising leads and blind alleys	23
Harnessing stem cell-based approaches for clinically meaningful discoveries in schizophrenia	23
Minority stress and schizophrenia-like experiences in sexual and gender minority adults	23
Brief video intervention to reduce stigma of family and friends of people living with serious mental illness	23
Augmentation of learning in schizophrenia by d-serine and auditory remediation is related to auditory and frontally-generated biomarkers: A randomized, double-blind, placebo-controlled study	22
The infraslow fluctuation of sigma power during sleep in young individuals with schizophrenia	22
Short-term antipsychotic treatment response in early-onset, typical-onset, and late-onset first episode schizophrenia	22
The impact of early intervention for first episode psychosis on cognitive functioning	22
Improving dependability in science: A critique on the psychometric qualities of the HiTOP psychosis superspectrum	22
Alteration in left frontoparietal connectivity correlates with impaired cognitive reappraisal in early psychosis	22
A call to action: Increased mortality from COVID-19 among individuals with schizophrenia calls for coordinated vaccination efforts	22
Differential gene expression study in whole blood identifies candidate genes for psychosis in African American individuals	22
Abnormalities in motor adaptation to different types of perturbations in schizophreniaperturbations in schizophrenia	22

What beneficial effects were maintained following a supervised high intensity interval training intervention among overweight individuals with psychotic disorders?	21
I am a person, not an illness	21
Overview on cognitive impairment in psychotic disorders: From impaired microcircuits to dysconnectivity	21
Investigation on the association between perceived family expressed emotion, self-stigma, and subjective quality of life in people with early psychosis in Hong Kong: A cross-sectional approach	21
Current progress in understanding schizophrenia using genomics and pluripotent stem cells: A meta-analytical overview	21
Determining the cumulative incidence of treated schizophrenia and predictors of transition in an early intervention for psychosis service	21
Characterization and modulation of voltage-gated potassium channels in human lymphocytes in schizophrenia	20
A systematic review of dramatherapy interventions used to support adults with psychosis	20
Sexual and gender minorities and psychosis research	20
Personal recovery in first-episode psychosis: Beyond clinical and functional recovery	20
Perceived burdensomeness and thwarted belongingness prospectively influence real-world social support-seeking behavior among emerging adults with first-episode psychosis	20
Corrigendum to “Jang YJ, et al. Characterizing the relationship between personality dimensions and psychosis-specific clinical characteristics” [Schizophr Res. 276 (2025) 88–96 10.1016/j.schres.2025.0	20
Promoting implementation of deployment-ready psychosocial interventions	20
Exploring the relationship between the gut microbiota and cognitive function in schizophrenia patients with distinct weights	20
Integrating rare variant genetics and brain transcriptome data implicates novel schizophrenia putative risk genes	20
Assessing negative symptoms of schizophrenia in the context of remote independent ratings: a psychometric evaluation of BNSS and PANSS	20
Switching a combination of first- and second-generation antipsychotic polypharmacy to antipsychotic monotherapy in long-term inpatients with schizophrenia and related disorders. The SwAP trial II: Res	20
Relations of temporoparietal connectivity with neighborhood social fragmentation in youth at clinical high-risk for psychosis	20
Factors and their weight in reducing life expectancy in schizophrenia	19
Racial microaggressions and major discriminatory events explain ethnoracial differences in psychotic experiences	19
Effects of PDE10A inhibitor MK-8189 in people with an acute episode of schizophrenia: A randomized proof-of-concept clinical trial	19
Acceptance and Commitment Therapy-based Lifestyle Counselling Program for people with early psychosis on physical activity: A pilot randomized controlled trial	19
Mitochondrial dysfunction in psychiatric disorders	19
Advancing the sensori-/psychomotor domain in schizophrenia spectrum disorders: From clinical observation to translational innovation	19
Issue highlights	19
Probing the molecular and cellular pathological mechanisms of schizophrenia using human induced pluripotent stem cell models	19
Personal recovery suits us all: A study in patients with non-affective psychosis, unaffected siblings and healthy controls	19
INTERACT: a randomized phase 2 study of the DAAO inhibitor luvadaxistat in adults with schizophrenia	19
Primary and secondary negative symptoms severity and the use of psychiatric care resources in schizophrenia spectrum disorders: A 3-year follow-up longitudinal retrospective study	19
Agoraphobic avoidance in patients with psychosis: Severity and response to automated VR therapy in a secondary analysis of a randomised controlled clinical trial	18
Aberrant salience predicts fluctuations of paranoia two weeks in advance during a 1-year experience sampling method study in people with psychosis	18
The phenomenological nature of schizophrenia and disorder of selfhood	18
Issue Highlights	18
Association between sleep disturbances and gray matter volume in individuals at clinical high-risk for psychosis and healthy controls: A longitudinal MRI study (NAPLS-3)	18
Neurocognitive function and delusion severity in schizophrenia spectrum disorders	18
Reprint of Altered corollary discharge in the auditory cortex could reflect louder inner voice experience in patients with verbal hallucinations, a pilot fMRI study	18
Food and nutrition insecurity among individuals with schizophrenia and related psychotic disorders	18
Olfactory dysfunction in schizophrenia and other psychotic disorders: A comprehensive and updated meta-analysis	18
Issue highlights	18
Associations between fearlessness about death and suicidal ideation in individuals with psychosis	18
Use and outcomes of antipsychotic medications for delusional and paranoid personality disorders: A population-based study	18
Response to the Letter to the editor: Aripiprazole or metformin for hyperprolactinemia in women with schizophrenia: A 6-month, real-world chart review study	18
Avolition predicts variability in optimal risk-taking in early psychosis	17
Exploring the relationship between baseline health-related quality of life (AQoL-4D utility values) and mortality during long-term follow-up for people living with a psychotic disorder	17
Catatonia is associated with higher rates of negative affect amongst patients with schizophrenia and schizoaffective disorder	17
Patient-reported outcome measures in early psychosis: A cross-cultural, longitudinal examination of the self-reported health and self-reported mental health measures in Chennai, India and Montreal, Ca	17
Modeling common and rare genetic risk factors of neuropsychiatric disorders in human induced pluripotent stem cells	17
MicroRNA-regulated suppression of some overexpressed genes in schizophrenia and their evolutionary significance	17
Multi-omics analysis reveals the impact of gut microbiota on antipsychotic-induced weight gain in schizophrenia	17
Hippocampal volume in affective and non-affective psychosis	17
The timing and severity of clozapine-associated neutropenia in the US: Is the risk overstated?	17
Increased prevalence of the Heschl's gyrus duplication pattern common to various first-episode psychoses	17
Language network self-inhibition and semantic similarity in first-episode schizophrenia: A computational-linguistic and effective connectivity approach	17
The association between area-level factors and mortality in severe mental illnesses: A systematic review	17
Arthur Schopenhauer: An underappreciated philosopher in psychiatry and his applied epistemology of body and self- experience	17
Sulfur-containing amino acids and risk of schizophrenia	16
Efficacy of KarXT on negative symptoms in acute schizophrenia: A post hoc analysis of pooled data from 3 trials	16
Perineuronal net density in schizophrenia: A systematic review of postmortem brain studies	16
Renaming schizophrenia in Argentina: Could a change of name resolve the stigma? Results from a national survey	16
Perceived stigma and self-stigma in young people at ultra-high risk for psychosis: Associations with identity-related, psychological and functional outcomes	16
Insight and suicidality in first-episode psychosis: The mediating role of depression	16
Pathways linking adverse childhood experiences to psychosis risk in Lagos, Nigeria: A structural equation modeling approach	16
Predicting future mortality risk in first-episode psychosis: External validation of the MIRACLE-FEP machine learning model	16
Alexithymia in chronic schizophrenia and its mediating effect between cognitive deficits and negative symptoms	16
Pathways to care: Source of referral at first-episode psychosis, a cross-country comparison between Bologna and South London	16
Comparative lipidomic alterations in the anterior cingulate cortex in schizophrenia and major depression	16
Does affect mediate the relationship between interpersonal trauma and psychosis? A systematic review and meta-analysis	16
Systematic review and meta-analysis of family-based interventions for early psychosis: Carer and patient outcomes	16
Disrupted static and dynamic small-world brain network topologies in patients with schizophrenia	16
Learning health systems in early interventions for psychosis: Establishing consumer voices in clinical high-risk for psychosis care	16
Relationship between psychopathological symptoms and dimensions in inpatients with schizophrenia: A network analysis	15
Reevaluating the assessment of nonverbal behavior in psychosis symptomatology: A call for cultural sensitivity	15
Antineuronal antibodies in cerebrospinal fluid and serum of 104 patients with psychotic disorders compared to 104 individually matched healthy controls	15
Single trajectory treatment response for predominant negative symptoms: Post-hoc analysis of a clinical trial with cariprazine and risperidone	15
Defeatist beliefs about performance are important treatment targets for negative symptoms in the early course of schizophrenia	15
Effect of schizophrenia risk gene polymorphisms on cognitive and neural plasticity	15
Schizophrenia, the very idea: On self-disorder, hyperreflexivity, and the diagnostic concept	15
Chicken or the egg: The relationship between cognitive deficits and negative symptoms in first episode psychosis	15
Treatment of schizotypal disorder: A systematic review and GRADE evaluation of the certainty of evidence	15
Editorial Board	15

Cannabidiol attenuates behavioral and electrophysiological changes in the MAM model of schizophrenia in male and female rats	15
Highlights	15
Longitudinal analysis of absolute neutrophil count (ANC) variability and neutropenia incidence in African American schizophrenia patients by ACKR1 genotype	15
A role for endothelial NMDA receptors in the pathophysiology of schizophrenia	15
Insulin resistance and lipid levels in the middle-aged offspring of parents with severe mental illness	15
Reshaping the diagnostic borders: Historical analysis of the diagnostic changes following the introduction of the schizophrenia concept	15
Predictors of early discontinuation of clozapine under rapid titration in a Turkish tertiary inpatient setting	14
Ultrastructural evidence for glutamatergic dysregulation in schizophrenia	14
The role of defeatist performance beliefs on cognitive effort-cost decision-making in schizophrenia	14
Levetiracetam effects on hippocampal blood flow and symptoms in medication-free individuals with nonaffective first episode psychosis (letter)	14
Motor activity-based prediction of the presence of apathy in schizophrenia	14
Evaluating the abnormal neural variability in schizophrenia: A TMS-EEG study	14
An integrative study of the microbiome gut-brain-axis and hippocampal inflammation in psychosis: Persistent effects from mode of birth	14
Automatic identification of schizophrenia employing EEG records analyzed with deep learning algorithms	14
Telomere biology and its maintenance in schizophrenia spectrum disorders: Exploring links to cognition	14
The contributions of risk-taking and impulsivity to jumping to conclusions in the psychosis spectrum	14
Initial evidence of vowel space reduction in a subset of individuals with schizophrenia	14
Subjective self-experiences at the mirror in patients with schizophrenia	14
Perceptual organization and its visual subcomponents in schizophrenia and schizotypy: A systematic review	14
Psychotic-like experiences in a nationally representative study of general population adolescents	14
Functional network interactions in patients with schizophrenia with persistent auditory verbal hallucinations: A multimodal MRI fusion approach using three-way pICA	14
Identifying clinical predictors for considering brain FDG-PET imaging in patients with catatonia: A case-control study	14
Negative mood states as a correlate of cognitive performance and self-assessment of cognitive performance in bipolar disorder versus schizophrenia	14
Relationships between neuropsychological performance, insight, medication adherence, and social metacognition in schizophrenia	14
Disentangling the relationship between psychiatric disorders, cardiometabolic abnormalities, and antipsychotics: A systematic review of genomic studies	14
Catatonia is an outpatient reality. What do we do now?	14
Microstructural white matter biomarkers of symptom severity and therapy outcome in catatonia: Rationale, study design and preliminary clinical data of the whiteCAT study	13
SARPEP, a rapid-learning healthcare system of early intervention services for psychosis in Quebec, Canada: Feasibility, acceptability and early impacts	13
Clozapine research standards in former USSR states: A systematic review of quality issues with recommendations for future harmonization with modern research standards	13
The use of adaptive emotion regulation strategies in people with attenuated psychotic symptoms – Results from a two-week diary study	13
Editorial Board	13
Exposome and cognition in psychosis: an exploratory study in sex-specific patterns in patients and their unaffected siblings	13
Sleep patterns in treated and untreated patients of schizophrenia	13
“The second I laid eyes on him I knew”: First impressions predict willingness to interact with individuals with schizophrenia	13
Social anhedonia in the daily lives of people with schizophrenia: Examination of anticipated and consummatory pleasure	13
Editorial Board	13
Dynamic or not, here I come: Ambulatory assessment of psychomotor ability for clinical predictions	13
Predicting the onset of psychotic experiences in daily life with the use of ambulatory sensor data – A proof-of-concept study	13
Cell line specific alterations in genes associated with dopamine metabolism and signaling in midbrain dopaminergic neurons derived from 22q11.2 deletion carriers with elevated dopamine synthesis capac	13
Young first-episode psychosis patients exhibit impaired microvascular function in the skin and low systemic nitric oxide availability, independent of classical cardiovascular risk factors	13
Decrease in gamma-band auditory steady-state response in patients with treatment-resistant schizophrenia	13
The introduction of clozapine at the Nathan Kline Institute in New York and its long-term consequences	13
Investigating bilirubin concentrations in schizophrenia: A systematic review and meta-analysis	13
Treatment resistance NMDA receptor pathway polygenic score is associated with brain glutamate in schizophrenia	13
Development and evaluation of a predictive biomarker model based on the niacin flush pathway for differentiating schizophrenia and bipolar disorder	13
Why and how might yoga differ from other mind-body approaches in schizophrenia?	13
Prenatal infection and schizophrenia: A decade of further progress	12
Feasibility and Acceptability of a Physical Activity Group Program Using telerehabilitation during the COVID-19 Pandemic in Multiple early Intervention for Psychosis Services	12
Self and time in individuals with schizophrenia: A motor component?	12
Promoting safer and wider worldwide use of clozapine	12
Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient data	12
Is it the end of the clozapine world as we know it? Perspectives on social implications of REMS elimination	12
Retinal electrophysiological alterations are associated with cognition in early course psychosis	12
Grey matter volume reduction in the frontotemporal cortex associated with persistent verbal auditory hallucinations in Chinese patients with chronic schizophrenia: Insights from a 3 T magnetic resonan	12
Negative symptoms in schizophrenia: Newly emerging measurements, pathways, and treatments	12
Clinical phenotypes of five patients with psychotic disorders carrying rare schizophrenia-associated loss-of-function variants	12
Clozapine in treatment-resistant schizophrenia: Who designed that famous US clinical trial?	12
The neuromuscular basis of functional impairment in schizophrenia: A scoping review	12
The cellular mechanism of antipsychotic-induced myocarditis: A systematic review	12
A scoping review of targeted psychological interventions for negative symptoms in schizophrenia	12
A psychological intervention for engaging dialogically with auditory hallucinations (Talking With Voices): A single-site, randomised controlled feasibility trial	12
Reply to dynamic network analysis of schizophrenia spectrum traits, affective symptoms, and social functioning—Opportunities and challenges	12
Clozapine ultrarapid metabolism during weak induction probably exists but requires careful diagnosis. A literature review, five new cases and a proposed definition	12
Editorial Board	12
Utilization of a psychosis consultation service: Early lessons from a statewide initiative	12
Long-term quality of life and social disconnection 20 years after a first episode psychosis, results from the 20-year follow-up of the OPUS trial	12
Issue Highlights	12
Randomized, double-blind, sham-controlled trial to evaluate the efficacy and tolerability of electroconvulsive therapy in patients with clozapine-resistant schizophrenia	12
Neuroanatomical subtypes of schizophrenia and relationship with illness duration and deficit status	12
The Remote Exercise And Lifestyle (REAL) intervention for first-episode psychosis: feasibility and preliminary effects of online group fitness training	12
Cross-disorder brain morphological similarity in schizophrenia: Associations with symptom severity and treatment outcome	12
Factor structure of social cognition in schizophrenia: Investigation of four core domains	12
Sub-clinical systemic inflammation as a determinant of admission duration in psychosis	12
Abnormalities in emotion regulation are associated with negative, but not positive or disorganized schizotypy: An experience sampling study	12
Editorial Board	12
Toxoplasmosis infection and schizophrenia: Elevated IgM reactivity index as a predictor of symptom worsening in chronic schizophrenia	12
Issue Highlights	12
Obsessive-compulsive symptoms and personal recovery in patients with schizophrenia spectrum disorders: A cross-sectional study	12
A systematic chart review of pharmacological interventions in patients with clozapine-induced hypersalivation	12
Hasty decision making and belief inflexibility in the more delusion prone? A modified disambiguating-scenarios paradigm assessing cognitive biases implicated in delusions	11
A systematic scoping review of rodent models of catatonia: Clinical correlations, translation and future approaches	11
The role of glutamate and GABA in cognitive dysfunction in schizophrenia and mood disorders – A systematic review of magnetic resonance spectroscopy studies	11
High rates of myocarditis with clozapine in the Hunter region of Australia	11
Subtyping chronic catatonia: Clinical and neuropsychological characteristics of progressive periodic catatonia and chronic system catatonias vs. non-catatonic schizophrenia	11
Access to cognitive remediation in Australia for people with schizophrenia	11
Higher central set point of thyroid homeostasis in drug-naïve patients affected by first episode schizophrenia	11
Psychopathology and psychosocial functioning among young people with first-episode psychosis and/or first-presentation borderline personality disorder	11
How does attachment affect help-seeking in people with paranoia and psychosis? The role of emotion regulation, self-stigma, and perceived support	11
Aberrant salience signaling in auditory processing in schizophrenia: Evidence for abnormalities in both sensory processing and emotional reactivity	11
White matter tracts differentially associated with auditory hallucinations in first-episode psychosis: A correlational tractography diffusion spectrum imaging study	11
Assessment of patient life engagement in schizophrenia using items from the Positive and Negative Syndrome Scale	11
Combining cognitive behavioral therapy and group training for social skills and cognition to improve negative symptoms in patients with psychotic disorders: a randomized controlled pilot trial	11
Racial disparities in utilization of first-generation versus second-generation long-acting injectable antipsychotics in Medicaid beneficiaries with schizophrenia	11
Disruption of NMDA receptor-mediated regulation of PPI in the maternal immune activation model of schizophrenia is restored by 17β-estradiol and raloxifene	11
Secondary psychosis revisited: Advancing detection, assessment and treatment	11